Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31802 total
MRNA dropped 7.8% on Tuesday to $187.46, its sharpest single-day move in weeks, and the decline narrows but does not close the extraordinary gap between where the stock trades and where Wall Street says it belongs. The…
Twist Bioscience enters the week with a jarring disconnect: the stock fell nearly 19% on Tuesday even as analysts scrambled to raise price targets, and the trigger was an unmistakable wave of insider selling at the…
StoneCo is at the centre of one of the most charged situations in EM fintech this week, with a fresh activist filing, a 25% rally, and options positioning that has turned decisively bullish, all arriving at once. The…
Ondas Inc. enters the week with the most stubborn short-side conviction in its recent history: a $165 million order haul that moved neither the short book nor the borrow market, and a stock sitting 0.9% lower on the…
Bloom Energy heads into its October 29 earnings date with a stock up 17% over the past month, short sellers steadily reducing exposure, and retail attention spiking to unusual levels, a convergence that sets up an…
Sigma Lithium draws fresh attention this week as a new institutional filing lands just as short-seller momentum shows its first signs of stalling. The most newsworthy development is the Schedule 13G filed by L1 Capital…
GLDM has pulled back 6% over the past month to $82.45, yet the borrowing market for the SPDR Gold MiniShares Trust tells a story of almost total indifference from short sellers. Short interest here is too small to…
XLC, the Communication Services Select Sector SPDR ETF, enters the second week of October with short sellers rebuilding positions at the fastest pace in months, even as the fund itself posts a solid weekly gain. The…
Equitable Holdings heads into its October 30 earnings with options traders leaning notably bullish, analysts nudging targets higher, and short sellers sitting in a structurally light position. The clearest read on…
Inspire Medical Systems enters the final stretch before its November 2 earnings with short interest climbing sharply on the week, a fresh bearish initiation from a major bank, and options traders positioned more…
NVT has gained 7.5% in the past week and sits at $173.80, yet options traders are now the most defensively positioned they have been all year, a tension worth unpacking three weeks from the next results date. The…
Spotify enters its October 22 earnings report in an unusual position: short sellers have been cutting positions at the same time retail attention has jumped to a two-standard-deviation high, while analysts are quietly…
AVGO closed the week at $375.81, up nearly 6% on the week, yet the Street's mean price target of $531 implies the stock still trades at a 41% discount to consensus. That gap is the central tension heading into December…
Zscaler emerged from its fiscal Q1 2027 earnings print with a wave of analyst upgrades and target raises pushing the stock 7% higher on the week, making the Street's reaction, not the positioning, the story worth…
VIR heads into its November 5 earnings with one of the most bullish options setups in over a year, even as short sellers hold a meaningful 13.3% of the float. The options market is the most striking data point this…
Guardant Health fell nearly 9% on Tuesday to close at $170.69, a striking single-day move that arrived even as Barclays raised its price target that same morning, a clear divergence between Street conviction and market…
VICI Properties heads into its October 28 earnings report with a steady drumbeat of analyst target cuts and a short position that has grown 18% over the past month, even as the borrow market remains exceptionally…
Penguin Solutions delivered its quarterly results on October 6, and the Street's response the following morning was swift and one-directional: analysts scrambled to raise price targets, leaving short sellers who held…
ZYME enters the final month before its November 6 earnings with a striking divergence: analysts have spent weeks raising targets, yet options traders are the most defensively positioned they have been all year. The…
SVRA heads into its November 11 earnings date with a contradictory setup: a fresh JP Morgan buy-side initiation at $12 landed this morning, yet shorts have been building for six weeks straight and the stock has shed…
